Ceftazidime Is the Key Diversification and Selection Driver of VIM-Type Carbapenemases
ABSTRACT In recent decades, carbapenems have been considered the last line of antibiotic therapy for Gram-negative bacterial infections. Unfortunately, strains carrying a high diversity of β-lactamases able to hydrolyze carbapenems have emerged in the clinical setting. Among them, VIM β-lactamases h...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | article |
| Language: | EN |
| Published: |
American Society for Microbiology
2018
|
| Subjects: | |
| Online Access: | https://doaj.org/article/c7e98d1d9a1843aa9ae8c889bf5f9b2d |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Be the first to leave a comment!